These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4217500)

  • 21. A Marek's disease vaccination trial.
    Lancaster JE; Barr WK; Bartlett BR
    Poult Sci; 1973 Jul; 52(4):1450-4. PubMed ID: 4773335
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of vaccination with avirulent herpesvirus on subsequent infection of chickens with virulent Marek's disease herpesvirus.
    Spencer JL; Robertson A
    Am J Vet Res; 1975 Aug; 36(08):1235-9. PubMed ID: 168799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parameters of infection in chicks exposed to Marek's disease by two different methods.
    Coles B; Cho BR; Kenzy SG
    Poult Sci; 1973 Sep; 52(5):1918-23. PubMed ID: 4202528
    [No Abstract]   [Full Text] [Related]  

  • 24. Oncogenesis of Marek's disease.
    Nazerian K
    Cancer Res; 1973 Jun; 33(6):1427-30. PubMed ID: 4578073
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus.
    Eidson CS; Page RK; Kleven SH
    Avian Dis; 1978; 22(4):583-97. PubMed ID: 219826
    [No Abstract]   [Full Text] [Related]  

  • 26. [Precipitins and neutralizing antibodies in Marek's disease].
    Kasabov R; Nikiforova M
    Vet Med Nauki; 1978; 15(4):27-32. PubMed ID: 105458
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative results of partial and total Marek's disease vaccination in broiler breeder flocks (author's transl)].
    Maas HJ; Rispens BH; Antonisse HW; Groenendal JE
    Tijdschr Diergeneeskd; 1973 Apr; 98(7):319-28. PubMed ID: 4792029
    [No Abstract]   [Full Text] [Related]  

  • 28. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.
    Rispens BH; van Vloten H; Mastenbroek N; Maas HJ; Schat KA
    Avian Dis; 1972 Apr; 16(1):108-25. PubMed ID: 4337307
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune responses of chickens fed the androgen analog mibolerone.
    Romero CH; Purchase HG; Frank F; Burmester BR; Kakuk TJ; Chang TS
    Avian Dis; 1977; 21(2):264-79. PubMed ID: 405963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with lyophilized turkey herpesvirus (HVT): minimum infective and protective doses.
    Patrascu IV; Calnek BW; Smith MW
    Avian Dis; 1972 Apr; 16(1):86-93. PubMed ID: 4623703
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against Marek's disease: possible causes of failure of herpesvirus of turkeys (strain FC126) to protect chickens against Marek's disease.
    Okazaki W; Purchase HG; Burmester BR
    Am J Vet Res; 1973 Jun; 34(6):813-7. PubMed ID: 4350544
    [No Abstract]   [Full Text] [Related]  

  • 33. Preservation of a T cell-mediated immune response in Marek's disease virus-infected chickens by vaccination with a related virus.
    Schierman LW; Theis GA; McBride RA
    J Immunol; 1976 May; 116(5):1497-9. PubMed ID: 774984
    [No Abstract]   [Full Text] [Related]  

  • 34. Growing performance of egg type chicks vaccinated with a Marek's disease vaccine.
    Goan HC; Sheppard CC; Purchase HG
    Poult Sci; 1972 Jan; 51(1):211-3. PubMed ID: 4643554
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
    Yoshida I; Yuasa N; Horiuchi T; Tsubahara H
    Natl Inst Anim Health Q (Tokyo); 1975; 15(1):1-7. PubMed ID: 804667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of infectious bursal agent on the response of chickens to Newcastle disease and Marek's disease vaccination.
    Giambrone JJ; Eidson CS; Page RK; Fletcher OJ; Barger BO; Kleven SH
    Avian Dis; 1976; 20(3):534-44. PubMed ID: 183651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marek's disease vaccine: prophylactic efficacy of a lyophilized turkey herpesvirus of chick cell-culture origin.
    Kilgore RL; Brokken ES
    Avian Dis; 1973; 17(1):137-41. PubMed ID: 4633273
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunomorphological changes in chicks vaccinated against Marek's disease with herpesvirus Sz-1].
    Enchev S; Kasabov R
    Vet Med Nauki; 1978; 15(7):53-60. PubMed ID: 219588
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the mechanism of vaccinal immunity to Marek's disease.
    Payne LN; Powell PC; Rennie MC; Ross LJ
    Comp Immunol Microbiol Infect Dis; 1978; 1(1-2):31-6. PubMed ID: 93038
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccination experiments against Marek's disease by application of an attenuated Marek herpesvirus and a turkey herpesvirus.
    Vielitz E; Landgraf H
    Prog Immunobiol Stand; 1971; 5():141-8. PubMed ID: 4660530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.